Efficacy and Safety of Third Dose of the COVID-19 Vaccine among Solid Organ Transplant Recipients: A Systemic Review and Meta-Analysis
Solid organ transplant recipients were demonstrated to have reduced antibody response to the first and second doses of the COVID-19 mRNA vaccine. This review evaluated published data on the efficacy and safety of the third dose among solid organ transplant recipients. We performed a systematic searc...
Main Authors: | Orly Efros, Roi Anteby, Mirit Halfon, Eshcar Meisel, Eyal Klang, Shelly Soffer |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/1/95 |
Similar Items
-
Humoral immune response following a third SARS-CoV-2 mRNA vaccine dose in solid organ transplant recipients compared with matched controls
by: Daniel Balsby, et al.
Published: (2022-12-01) -
Reduced Neutralization Efficacy against Omicron Variant after Third Boost of BNT162b2 Vaccine among Liver Transplant Recipients
by: Yana Davidov, et al.
Published: (2023-01-01) -
Serological Responses after a Fourth Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis
by: Yameng Mu, et al.
Published: (2023-06-01) -
Current Perspectives on the Management of Herpesvirus Infections in Solid Organ Transplant Recipients
by: S. Reshwan K. Malahe, et al.
Published: (2023-07-01) -
Infections in the solid-organ transplant recipients
by: Manal El Said
Published: (2021-04-01)